Campagna A. Jason's most recent trade in Q32 Bio Inc. was a trade of 87,738 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Q32 Bio Inc. | Jason A. Campagna | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 87,738 | 0 | - | - | Stock Option (Right to Buy) | |
Q32 Bio Inc. | Jason Campagna A. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 87,738 | 87,738 | - | - | Stock Option (Right to Buy) | |
Q32 Bio Inc. | Jason Campagna A. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 70,687 | 70,687 | - | - | Stock Option (Right to Buy) | |
Q32 Bio Inc. | A. Jason Campagna | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 70,687 | 0 | - | - | Stock Option (Right to Buy) | |
Q32 Bio Inc. | Campagna A. Jason | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 37,500 | 37,500 | - | 0 | Common Stock | |
Q32 Bio Inc. | Jason Campagna A. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 17,951 | 17,951 | - | - | Stock Option (Right to Buy) | |
Q32 Bio Inc. | Campagna Jason A. | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 17,951 | 0 | - | - | Stock Option (Right to Buy) | |
Q32 Bio Inc. | Jason A. Campagna | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 70,687 | 70,687 | - | - | Stock Option (Right to Buy) |